|
Gender-specific addiction research needed now more than ever: Reflections from 25 years of the NIDA Clinical Trials Network Gender Special Interest Group |
Journal of Substance Use and Addiction Treatment |
2025 |
|
Factors associated with mortality following hospitalization among veterans with opioid use disorder |
Journal of Substance Use and Addiction Treatment |
2025 |
|
Baseline Moderators of Response to Naltrexone and Bupropion in the Treatment of Methamphetamine Use Disorder: An ADAPT-2 Study |
Journal of Addiction Medicine |
2025 |
|
Clinical pharmacist practitioners prescribing of buprenorphine for opioid use disorder |
Drug and Alcohol Dependence |
2025 |
|
Randomized Pilot of a Clinical Decision Support Tool to Increase Suicide Screening for at-Risk Primary Care Patients With Opioid Use Disorder |
AJPM Focus |
2024 |
|
Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial |
Addiction |
2024 |
|
Barriers and Facilitators to Using a Clinical Decision Support Tool for Opioid Use Disorder in Primary Care |
Journal of the American Board of Family Medicine |
2024 |
|
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder |
Addiction Science and Clinical Practice |
2024 |
|
Providers' Experiences and Perspectives in Treating Patients With Co-Occurring Opioid and Stimulant Use Disorders in the Hospital |
Substance Use and Addiction Journal |
2024 |
|
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus |
Addiction Science and Clinical Practice |
2024 |
|
Sociodemographic and patient reported outcomes by racial and ethnicity status among participants in a randomized controlled trial for methamphetamine use disorder |
Drug and Alcohol Dependence Reports |
2024 |
|
Wiidookaage'win: Beta-test of a Facebook group intervention for Native women to support opioid use recovery |
Journal of Substance Use & Addiction Treatment |
2024 |
|
Delivering MOUD to the Underserved: How Can Pharmacies Really Help? |
Journal of Studies on Alcohol and Drugs |
2024 |
|
Hospital Addiction Medicine Consultation Service Orders and Outcomes by Patient Race and Ethnicity in an Urban, Safety-Net Hospital |
Journal of General Internal Medicine |
2024 |
|
Wiidookaage'Win: A Community-Based Qualitative Approach to Developing a Facebook Group Intervention for Native Women to Support Recovery From Opioid Use |
American Journal of Health Promotion |
2024 |
|
A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians |
Addiction Science & Clinical Practice |
2023 |
|
Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration |
Drug and Alcohol Dependence |
2023 |
|
Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care |
Contemporary Clinical Trials |
2023 |
|
Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial |
JAMA Internal Medicine |
2023 |
|
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR16) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial |
Neuropsychiatric Disease and Treatment |
2023 |
|
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy |
Substance Abuse |
2023 |
|
Sexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorder |
Drug and Alcohol Dependence |
2023 |
|
Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder |
JAMA Health Forum |
2022 |
|
Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year |
Journal of Substance Abuse Treatment |
2022 |
|
Rethinking the Use of "Polysubstance" to Describe Complex Substance Use Patterns |
Journal of General Internal Medicine |
2022 |
|
A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder |
Addiction Science & Clinical Practice |
2021 |
|
Bupropion and Naltrexone in Methamphetamine Use Disorder |
The New England Journal of Medicine |
2021 |
|
Clinician Perceptions About a Decision Support System to Identify and Manage Opioid Use Disorder |
Journal of the American Board of Family Medicine |
2021 |
|
Financial sustainability of payment models for office-based opioid treatment in outpatient clinics |
Addiction Science & Clinical Practice |
2021 |
|
Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV |
Journal of General Internal Medicine |
2021 |
|
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment |
Addiction Science & Clinical Practice |
2021 |
|
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems |
Addiction Science & Clinical Practice |
2021 |
|
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report |
Substance Abuse |
2021 |
|
Service Involvement Across Multiple Sectors Among People Who Use Opioids, Methamphetamine, or Both, United States-2015-2018 |
Medical Care |
2021 |
|
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report |
Addiction Science & Clinical Practice |
2020 |
|
Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems |
Journal of Substance Abuse Treatment |
2020 |
|
Prevalence and treatment of opioid use disorders among primary care patients in six health systems |
Drug and Alcohol Dependence |
2020 |
|
A Quality Framework for Emergency Department Treatment of Opioid Use Disorder |
Annals of Emergency Medicine |
2019 |
|
Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis |
Journal of Substance Abuse Treatment |
2019 |
